Managing malignancies of the eye and surrounding structures demands early detection and highly individualized treatment strategies. The field of ocular oncology and orbital tumors brings together diagnostic imaging, histopathology, and molecular profiling to improve patient outcomes. From retinoblastoma in children to ocular melanomas and lymphoproliferative lesions in adults, these conditions require a multidisciplinary approach involving oncologists, ophthalmologists, and radiologists. Technological advances in orbital imaging and targeted therapy are allowing for more conservative treatment plans, reducing the need for enucleation while preserving vision and aesthetics. Surgical precision in orbital tumor resection continues to improve with intraoperative navigation tools. Moreover, attention is growing around survivorship care, addressing both visual rehabilitation and cosmetic reconstruction. As researchers uncover genetic markers and develop immunotherapeutic options, the prognosis for orbital and intraocular tumors is gradually improving, highlighting the need for continued collaboration across oncology and vision science disciplines.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Targeting immunological pathways in Behcet's uveitis
Hashim Butt, Bolton Royal Hospital, United Kingdom
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : The effect of low hypermetropia correction and office-based orthoptic training on binocular vision parameters in children with convergence insufficiency
Agnieszka Rosa, Orticus Center for the Treatment of Strabismus and Vision Disorders, Poland
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom